2020
DOI: 10.1007/s11356-020-09998-1
|View full text |Cite
|
Sign up to set email alerts
|

SLC16A1-AS1 enhances radiosensitivity and represses cell proliferation and invasion by regulating the miR-301b-3p/CHD5 axis in hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 59 publications
2
15
0
Order By: Relevance
“…LNC00242 was high-expressed in gastric cancer (GC) tissue regulated by LINC00242/miR-1-3p/G6PD axis (Deng et al, 2021), and it may be a promising biomarker of GC (Zhong et al, 2020). Mediated by E2F1, SLC16A1-AS1 could progress bladder cancer to the invasive stage (Logotheti et al, 2020) and serve as a new diagnostic indicator in hepatocellular carcinoma (Song et al, 2019;Pei et al, 2020). It has been reported that SLC25A5-AS1 functions as a suppressor in the progression of gastric cancer to regulate cellular behaviors via the miR-19a-3p/PTEN/PI3K/AKT signaling pathway (Li et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…LNC00242 was high-expressed in gastric cancer (GC) tissue regulated by LINC00242/miR-1-3p/G6PD axis (Deng et al, 2021), and it may be a promising biomarker of GC (Zhong et al, 2020). Mediated by E2F1, SLC16A1-AS1 could progress bladder cancer to the invasive stage (Logotheti et al, 2020) and serve as a new diagnostic indicator in hepatocellular carcinoma (Song et al, 2019;Pei et al, 2020). It has been reported that SLC25A5-AS1 functions as a suppressor in the progression of gastric cancer to regulate cellular behaviors via the miR-19a-3p/PTEN/PI3K/AKT signaling pathway (Li et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…LNC00242 was high-expressed in gastric cancer (GC) tissue regulated by LINC00242/miR-1-3p/G6PD axis [21], it may be a promising biomarker of GC [22]. Mediated by E2F1, SLC16A1-AS1 could progress bladder cancer to invasive stage [23], and sever as a new diagnostic indicator in hepatocellular carcinoma [24,25]. It has been reported that SLC25A5-AS1 functions as a suppressor in the progression of gastric cancer to regulate cellular behaviors via miR-19a-3p/PTEN/PI3K/AKT signaling pathway [26].…”
Section: Discussionmentioning
confidence: 99%
“…Hence, it is important to understand and correlate the expression of MCTs and ECMs in different compartments. Our analysis revealed nine differentially expressed MCT genes in both stromal and epithelial samples, including the upregulated thyroid hormone (TH) transporters MCT8 ( SLC16A12 ) and MCT10 ( SLC16A10 ), monocarboxylate transporter MCT2 ( SLC16A7 ), MCT6 ( SLC16A5 ) with a potential role in glucose and lipid metabolism, and an lncRNA SLC16A1-AS1 previously identified as a prognostic or diagnostic biomarker in a number of cancers [ 20 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 ]. To our knowledge, the upregulation of the TH transporters in the stromal–epithelial samples has not been highlighted previously.…”
Section: Discussionmentioning
confidence: 99%